Pharma sales reps often find the doc won't see them now
Wall Street Journal Health Blog, April 17, 2009
New figures from sales and marketing consultants ZS Associates indicate drug reps do not get in the door to see a doctor on 13% of their visits. The 18 million wasted sales calls each year suggest the extent of a physician backlash against pharma's marketing push, says Jaideep Bajaj, managing director of ZS Associates. ZS Associates hasn't been tracking the success rate for rep visits for very long but it's clear that doctor access is getting squeezed for the drug-company detailers, according to the Wall Street Journal Health Blog.
Most Viewed
Most Emailed
- $6.4B Henry Ford, Beaumont Merger Failed on Cultural Hurdles
- How Chargemaster Data May Affect Hospital Revenue
- Primary Care Docs Average More Hospital Revenue Than Specialists
- House Lawmakers Grill CMS Over Health Exchange Navigators
- Fortunately, Angelina Jolie Isn't On Medicare
- ED Physicians Key to Half of Hospital Admissions
- Don't Let Nurses Sink Your Bottom Line
- Insurer's App Aims to Lower Healthcare Costs, Securely
- 69% of Employers Plan to Offer Healthcare Coverage After 2014
- Building a Better Healthcare Board
